alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Orient Paper, Inc. (the Company) on
Form 10-Q for the period ended June 30, 2009, as filed with the Securities and
Exchange Commission on the date hereof (the Report), I, Zhenyong Liu, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350
of the Sarbanes-Oxley Act of 2002, that:

| |     |                                                                                                                                                         
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) | The Report fully complies
  with the requirements of section 13(a) or 15(d) of the Securities Exchange
  Act of 1934; and                               
| |     |                                                                                                                                                         
| | (2) | The information contained
  in the Report fairly presents, in all material respects, the financial
  condition and results of operations of the Company.

A
signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to
the Securities and Exchange Commission or its staff upon request.

The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before
or after the date hereof, regardless of any general incorporation language in
such filing.

|                      |     |                                
|--------------------- | --- | -------------------------------
|Date: August 14, 2009 | By: | /s/ Zhenyong Liu               
|                      |     |                                
|                      |     | Zhenyong Liu                   
|                      |     | Chief Executive Officer        
|                      |     | (principal executive
  officer)

---
#### The People of the State of New York ex rel. Michael Aziz Zarif Shabazz, Also Known as Michael Hurley, Appellant, v Jerome J. Richards, Acting Judge of Franklin County Court, et al., Respondents.

Submitted November 5, 2012;

decided December 18, 2012

*984Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the proceeding within the meaning of the Constitution.
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, May 25, 2017.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, May 25, 2017

The Court of Appeals hereby passes the following order

A17A0582. CLARENCE DARRAL RUFFIN v. THE STATE.

Upon consideration of the APPELLANT'S motion FOR PERMISSION TO WITHDRAW 

THE APPEAL in the above styled case, it is ordered that the motion is hereby GRANTED.
# Congenital Myasthenia

## What is congenital myasthenia?

Congenital myasthenia is an inherited disorder that usually develops at or near birth or in early childhood and involves muscle weakness and fatigue. It happens when chemicals called neurotransmitters that help relay information between the nerve cells and muscles aren't properly released and received. 

There are several types of congenital myasthenia that are caused by specific gene mutations. Symptoms of congenital myasthenia include:

In babies
              - Lack of muscle control
              - Not meeting development goals like rolling over or sitting

In older children
              - Weakness while doing physical activity
              - Droopy eyelids, a “lazy eye,” or double vision (d iplopia)
              - Difficulty talking or swallowing

Congenital myasthenia can be identified by the weakness getting worse with activity and feeling better with rest. Medicine is used to treat congenital myasthenia by improving the signaling between nerves and muscles.

file-medical

## How can I or my loved one help improve care for people with congenital myasthenia?

Consider participating in a clinical trial so clinicians and scientists can learn more about the congenital myasthenia and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease. 

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them. 

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with congenital myasthenia at Clinicaltrials.gov.
> Where can I find more information about congenital myasthenia?
The following resources may help:

Genetic and Rare Diseases (GARD) Information Center

MedlinePlus

book-open
Exhibit
32.1





Certification of Principal
Executive Officer


Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to


Section
906 of the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report
of Scout Acquisition, Inc. (the "Company") on Form 10-Q for the period ended
September 30, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Scott Baily, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/ Scott BailyScott
      BailyPrincipal
      Executive OfficerNovember
      13, 2009
[Federal Register Volume 74, Number 120 (Wednesday, June 24, 2009)]
[Notices]
[Pages 30105-30106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14912]


-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

U.S. Customs and Border Protection


Approval of Saybolt LP, as a Commercial Gauger

AGENCY: U.S. Customs and Border Protection, Department of Homeland 
Security.

ACTION: Notice of approval of Saybolt LP, as a commercial gauger.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that, pursuant to 19 CFR 151.13, 
Saybolt LP, 905C Eastern Blvd., Clarksville, IN 47129, has been 
approved to gauge petroleum, petroleum products, organic chemicals and 
vegetable oils for customs purposes, in accordance with the provisions 
of 19 CFR 151.13. Anyone wishing to employ this entity to conduct 
gauger services should request and receive written assurances from the 
entity that it is approved by the U.S. Customs and Border Protection to 
conduct the specific gauger service requested. Alternatively, inquiries 
regarding the specific gauger service this entity is approved to 
perform may be directed to the U.S. Customs and Border Protection by 
calling (202) 344-1060. The inquiry may also be sent to 
<a href="/cdn-cgi/l/email-protection#95f6f7e5bbf9f4f7fde4d5f1fde6bbf2fae3"><span class="__cf_email__" data-cfemail="6e0d0c1e40020f0c061f2e0a061d40090118">[email protected]</span></a>. Please reference the Web site listed below for a 
complete listing of CBP approved gaugers and accredited laboratories.
    http://cbp.gov/xp/cgov/import/operations_support/labs_scientific_svcs/commercial_gaugers/

DATES: The approval of Saybolt LP, as commercial gauger became 
effective on September 10, 2008. The next triennial inspection date 
will be scheduled for September 2011.

FOR FURTHER INFORMATION CONTACT: Anthony Malana, Laboratories and 
Scientific Services, U.S. Customs and Border Protection, 1300 
Pennsylvania

[[Page 30106]]

Avenue, NW., Suite 1500N, Washington, DC 20229, 202-344-1060.

    Dated: June 18, 2009.
Ira S. Reese,
Executive Director, Laboratories and Scientific Services.
[FR Doc. E9-14912 Filed 6-23-09; 8:45 am]
BILLING CODE 9111-14-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED FE BRUARY 12, 2015

NO. 03

- 12

- 00808

- CR

Andre Demar Gipson, Appellant

v.

The State of Texas, Appellee

APPEAL FROM 331ST DISTRICT COURT OF TRAVIS COUNTY

BEFORE JUSTICES PEMBERTON, GOODWIN, AND FIELD

MODIF IED AND, AS MODIFIED, AFFIRMED

-- OPINION BY JUSTICE FIELD

This is an appeal from the judgment of conviction rendered by the tr i a l court. Having reviewed

the record and the parties’ arguments, the Court ho lds that there was no r eversible error in the

court’s judgment of conviction but that there was error requiring correction . Therefore, the

Court modifies the trial court’s judgment as follows: to change the phrase “29.03 Health and

Safety Code” to “29.03 Penal Code ;” and to ref lect that appellant ple a d ed true to an enhancement

allegation . The judgment, as modified, is affirmed

. Because appellant is indigent and unable to

pay costs, no adjudication of costs is made.
97-766.

#### State v. Samples.

Hamilton App. No. C-960241. On motion for leave to file delayed appeal. Motion denied.

Moyer, C.J., Pfeifer and Cook, JJ., dissent.
The Honorable Andrew W. Bogue, United S tates District Judge for the District 1 of South Dakota, sitting by designation. United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 97-2839

___________ Thomas McDonald, * * Plaintiff - Appellant, * * Appeal from the United States v. * District Court for the Western * District of Missouri John Deere Company; Deere & * Company, * [UNPUBLISHED] * Defendants - Appellees. *

___________ Submitted: February 11, 1998 Filed: April 8, 1998

___________ Before WOLLMAN and LOKEN, Circuit Judges , and BOGUE, Senior Distric t 1 Judge.

___________ PER CURIAM. Thomas McDonald appeals from the adverse de cisions of the judge and the jury in this product liability lawsu it. After a careful review of the law and the record in this case, we reject McDonald's contention that the district court improperly-2-

grantedpartial summary judgment to Deere on McDonald's claim that Deere owed a duty t o McDonald to equip a mower with a rollover protection system. We likewis e reject McDonald's contention that the district court misinstructed the jury on the issue of ass umption of the risk/contributory fault. Having reviewed the challenge d instructions under the appropriate standards of review, we conclude that the y accurately reflect the applicable law and do not require reversal. We further find that there i s sufficien t evidence in support of the jury verdict. Having considered McDonald' s remai ning contentions under well-established standards, we find no error that woul d require rever sal. Because an opinion would have no precedential value, we affirm the district court without further discussion. See 8th Cir. R. 47B. A true copy. ATTEST: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
**EXHIBIT
        32.1**


CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002








In
      connection with the quarterly report of ES Bancshares, Inc. (the “Company”) on
      Form 10-QSB for the period ending September 30, 2007 as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Anthony
      P. Costa, Chairman and Chief Executive Officer of the Company, certify, pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that:




(1)
            The
                report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.








Date:      
      November 8,
      2007                       /s/
      Anthony P
      Costa


Anthony
      P. Costa


Chairman
      and Chief Executive
      Officer
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 97-40725 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus ERASMO FERNANDEZ, also known as Eddie, Defendant-Appellant.

- - - - - - - - - - Appeal from the United States District Court for the Eastern District of Texas USDC No. 4:94-CR-3-6

- - - - - - - - - - June 17, 1998 Before DAVIS, PARKER, and DENNIS, Circuit Judges.
PER CURIAM: * Erasmo Fernandez, federal prisoner #64973-079, appeals from the denial of his motion for a reduction of his sentence pursuant to 18 U.S.C. § 3582(c)(2). Fernandez’s motion for appointment of counsel is DENIED. Fernandez contends that amendments 484 and 516 to the Sentencing Guidelines should be applied retroactively to his case. Fernandez raises his contention regarding amendment 484 for the first time on appeal; accordingly, our review is forNo. 97-40725 -2- plain error. United States v. Calverley , 37 F.2d 160, 162-64 (5th Cir. 1994)(en banc). Amendment 484 became effective before Fernandez was sentenced. Section 3582(c)(2) provides relief only in the event of certain enumerated post-sentencing amendments to the guidelines. Fernandez has not demonstrated error, plain or otherwise, because the district court did not reduce his sentence pursuant to the amendment. Fernandez has failed to brief adequately his contention that amendment 516 should have been applied to reduce his sentence. We do not excuse his failure to brief the issue; we therefore do not consider the issue. Grant v. Cuellar , 59 F.2d 523, 525 (5th Cir. 1995). This appeal is frivolous. APPEAL DISMISSED. 5 TH C IR . R. 42.2.
# Eating Disorders

Eating disorders are serious and sometimes fatal illnesses that cause severe disturbances to a person’s eating behaviors. Obsessions with food, body weight, and shape may also signal an eating disorder. Common eating disorders include binge eating disorder, bulimia nervosa, and, less common but very serious, anorexia nervosa.

Additional information about eating disorders can be found on the NIMH Health Topics page on Eating Disorders.

## Definitions

### Binge Eating Disorder

- Binge eating disorder  is characterized by recurrent binge eating episodes during which a person feels a loss of control and marked distress over his or her eating. Unlike bulimia nervosa, binge eating episodes are not followed by purging, excessive exercise or fasting. As a result, people with binge eating disorder often are overweight or obese.

### Bulimia Nervosa

- Bulimia nervosa  is characterized by binge eating (eating large amounts of food in a short time, along with the sense of a loss of control) followed by a type of behavior that compensates for the binge, such as purging (e.g., vomiting, excessive use of laxatives, or diuretics), fasting, and/or excessive exercise. Unlike anorexia nervosa, people with bulimia can fall within the normal range for their weight. But like people with anorexia, they often fear gaining weight, want desperately to lose weight, and are intensely unhappy with their body size and shape.

### Anorexia Nervosa

- Anorexia nervosa  is characterized by a significant and persistent reduction in food intake leading to extremely low body weight in the context of age, sex, and physical health; a relentless pursuit of thinness; a distortion of body image and intense fear of gaining weight; and extremely disturbed eating behavior. Many people with anorexia see themselves as overweight, even when they are starved or severely malnourished.

## Age of Onset

Based on diagnostic interview data from the National Comorbidity Survey Replication (NCS-R), median age of onset was 21 years-old for binge eating disorder and 18 years-old for both bulimia nervosa and anorexia nervosa.1

## Prevalence of Eating Disorders in Adults

Based on diagnostic interview data from the NCS-R, the data below indicate the past year prevalence of each type of eating disorder among U.S. adults aged 18 and older. 1

### Binge Eating Disorder

- Figure 1 shows the past year prevalence of binge eating disorder in adults.	   - The overall prevalence of binge eating disorder was 1.2%.
  - Prevalence of binge eating disorder was twice as high among females (1.6%) than males (0.8%).
- Based on Sheehan Disability Scale associated with past year behavior, 62.6% of people with binge eating disorder had any impairment and 18.5% had severe impairment.
- The lifetime prevalence of binge eating disorder was 2.8%.

#### Figure 1
EXHIBIT 32.2





CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO


18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b)


(Section 906 of the Sarbanes-Oxley Act of 2002)




In connection with the Amended Quarterly Report of Neuralstem, Inc. (the “Company”) on Form 10-Q/A for the period ending March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Conron, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:





(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company.





/s/John ConronJohn ConronChief Financial Officer

(Principal Financial Officer)

Neuralstem, Inc.





This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
#     Sudha Srinivasan, Ph.D, M.P.H.  

Dr. Sudha Srinivasan’s interests are broad and include host response to disease, particularly from a host genetics perspective, the ethical, social and legal aspects of research, helping bridge the divide between basic and clinical research and fostering domestic and international collaborations in public health, to strengthen and promote health research across the globe. She is especially passionate about research capacity building in low and middle-income countries, and in the intersection of global health, health equity and health disparities.

sudha.srinivasan@nih.gov

240-281-0303

----

Dr. Sudha Srinivasan has over 25 years of cumulative professional experience in leading, implementing, coordinating, and managing a breadth of multilateral public health programs and projects, both, international and domestic in scope and impact. Dr. Srinivasan has worked in Global Health for most of her professional career, and at multiple institutes at the NIH which includes National Human Genomics Research Institute, the Fogarty International Center, the National Institutes of Allergy and Infectious Diseases and USG agencies such as the United States Agency for International Development (USAID), in addition to private sector experience.  She has worked and managed projects in a wide variety of subject areas ranging from infectious and non-communicable diseases, maternal and child health, nutrition, food security, genomics/ genetics and implementation science.

Dr. Srinivasan obtained her doctoral degree focused on Human Genetics and Molecular Biology from the University of Pennsylvania, and a Master of Public Health degree, from the Johns Hopkins University; and she also served as a AAAS Diplomacy fellow at USAID.
IV 

116TH CONGRESS 

1ST SESSION H. RES. 418 

Expressing support for recognition of June 2019 as National Orca Protection 

Month. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 3, 2019 

Mr. HECK submitted the following resolution; which was referred to the 

Committee on Oversight and Reform 

RESOLUTION 

Expressing support for recognition of June 2019 as National 

Orca Protection Month. 

Whereas orcas are an icon of the Pacific Northwest; 

Whereas orcas are culturally and spiritually important to Indian Tribes in the Pacific Northwest; 

Whereas the Puget Sound is home to three pods of Southern 

Resident orcas; 

Whereas the Southern Resident orca population has declined 

dramatically over the past 50 years; 

Whereas the Southern Resident orcas are among the most 

contaminated marine mammals in the world; 

Whereas the Southern Resident orcas are threatened by declining chinook salmon populations; 


kjohnson on DSK79L0C42 with BILLS
2 

•HRES 418 IH 

Whereas the Southern Resident orcas have been protected 

under the Endangered Species Act of 1973 (16 U.S.C. 

1531 et seq.) since 2005 and are one of the most endangered marine mammal populations in the world; 

Whereas June 2019 has been recognized by the States of 

Washington and Oregon as Orca Awareness Month; and 

Whereas the Federal Government has an obligation to protect 

and restore the Southern Resident orca population: Now, 

therefore, be it 

1 Resolved, That the House of Representatives supports 

2 recognition of National Orca Protection Month. 

Æ 


kjohnson on DSK79L0C42 with BILLS
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

B.S.,

Respondent

v.

S.P.,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 577 MAL 2020

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 29th day of March, 2021, the Petition for Allowance of Appeal is 

DENIED.
Exhibit 10.33


 





 


August 11, 2022


 


Nauticus Robotics Inc.


17146 Feathercraft Lane


Webster, TX 77598


Attention: Nicolaus Radford


 


Ladies and Gentlemen:


 


Reference is hereby made to that certain letter agreement (the “Agreement”),
dated March 23, 2022, between Cowen and Company, LLC (“Cowen”) and Nauticus Robotics Inc. (the “Company”). Capitalized
terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.


 


Pursuant to Section 2 of the Agreement, Cowen is hereby providing the
Company with ten days’ written notice of termination of the Agreement. Cowen is hereby waiving its right to reimbursement of expenses
and the Residual Period. All other provisions of the Agreement that survive termination shall continue to survive.


 


Very truly yours,


 


COWEN AND COMPANY, LLC


 


	By:	/s/ Peter Finn	 
	Name: 	Peter Finn	 
	Title:	Managing Director	 


 


Cowen and Company, LLC


599 Lexington Avenue, 20th Floor


New York, NY
10022


T 646 562 1010


www.cowen.com